Merck, the maker of the melanoma drug Keytruda is accusing Pharmac of ignoring the latest data on the drug's effectiveness.
Recent stories from Morning Report
Get the RNZ app
for easy access to all your favourite programmes
for easy access to all your favourite programmes
